Leverage our expertise in nanomilling and spray drying to address low solubility and improve the bioavailability and efficacy of challenging drug compounds.

Discover how early clinical cognitive testing and dedicated driving simulation studies can help assess the cognitive functions for safety and efficacy in drug development.

In this article, we provide a detailed overview of the multiple facets you need to consider during the planning and conduct of your CNS-active drug development.

Industry experts explore the regulatory challenges of Schedule 1 drug development, including required studies, specialized assessments, and key formulation and manufacturing considerations.

Explore the unique challenges faced in the formulation development of ocular therapies and how they can be overcome to ensure safe, efficient, and targeted treatments for patients.

Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.

To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.

Navigating the landscape of ophthalmic drug development can be challenging. Check out this scientific journal that outlines potential challenges, and how to overcome them.

Discover the benefits of liquid-filled capsules for efficient, scalable, and patient-friendly drug manufacturing, and how they can enhance bioavailability and simplify complex formulations.

Discover why gathering and analyzing pharmacokinetic (PK) and pharmacodynamic (PD) data is key — from preclinical studies right to clinical trial conduct.

Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

Regulatory agencies prefer terminal sterilization over aseptic manufacturing, but is it suitable for your product? Industry manufacturing experts guide you in the selection and final delivery.

Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.

Gain valuable insights into the cutting-edge approaches shaping the future of gene and cell therapy delivery, ensuring more effective and efficient translation from discovery to clinical application.

<p>Learn how CROs and CDMOs work in tandem to successfully address operational and regulatory challenges for pharmaceutical and biotech companies, and how this can determine study success or failure.</p>

Learn about key topics in nanomilling, including practical applications and advantages, specialized equipment, milling media, stabilizers, as well as manufacturing and scale-up considerations.

Discover the advantages of LFHCs, including improved solubility and bioavailability, enhanced stability, and customizable release profiles, and how they can accelerate drug development timelines.

Learn how CROs and CDMOs work in tandem to address operational and regulatory challenges for pharmaceutical and biotech companies, and how this can determine study success or failure.

Learn more about the benefits of nanomilling, types of milling media and stabilizers, and scale up for clinical manufacturing.